Cetylpyridinium chloride - ARMS Pharmaceutical

Drug Profile

Cetylpyridinium chloride - ARMS Pharmaceutical

Alternative Names: ARMS-I; CPC

Latest Information Update: 07 Mar 2017

Price : $50

At a glance

  • Originator ARMS Pharmaceutical
  • Class Antiseptics; Disinfectants; Pyridinium compounds; Small molecules
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Viral infections

Most Recent Events

  • 07 Mar 2017 Chemical structure information added
  • 06 Feb 2017 ARMS Pharmaceutical has patents pending for ARMS-I platform in USA, Europe, Japan, China, Brazil, India, Korea, Canada, Mexico, Israel (ARMS Pharmaceutical, February 2017)
  • 01 Feb 2017 NCT03026205 - new profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top